buy sell hold 

 

UOB KAYHIAN UOB KAYHIAN 

 

InnoTek (INNOT SP)

Riding On China’s Auto Sales Recovery And High TV Demand

 

InnoTek, which has a huge exposure to China’s auto market, is a precision metal components manufacturer automation industries. It is set to benefit from: a) China’s auto sales recovery; and b) COVID-19 social distancing measures which have boosted demand for large screen TVs. We expect 2H20 EPS to grow by 229% hoh and 19.4% yoy in 2021. InnoTek has a net cash position of S$73m. We initiate coverage with BUY and PE-based target price of S$0.82.

 

Read More ...

 

Jiutian Chemical Group (JIUC SP)

3Q20: Earnings Overshoot Expectations; DMF ASP Higher Than Expected

 

3Q20 net profit of Rmb51.9m (+2,038% yoy, +59% qoq) overshot our estimate of Rmb38.8m, due mainly to higher-than-expected DMF ASP. While spot DMF prices are seeing some softening since our stock initiation, they are expected to stay elevated due to sustainable demand. We lift our 2021F DMF ASP assumption slightly by 2.9% to Rmb7,200/tonne, keeping a healthy buffer of 30% below the current spot price of Rmb9,350/tonne. Maintain BUY with higher target price of S$0.18.

 

Read More ...

UOB KAYHIAN

MAYBANK KIM ENG

Elite Commercial REIT (ELITE SP)

Maiden Acquisition Diversifies Mix Of Sovereign Tenants

 

Elite has announced its first acquisition since listing, of 58 commercial buildings for £212.5m. About 36% of the new properties are in London, and this will increase Elite’s London portfolio exposure to 14%, provide higher potential growth for rent and capital values as well as opportunities for future redevelopment. Maintain BUY and target price of £0.88.

 

Read More ...

 

Valuetronics (VALUE SP)

Earnings recovery delayed

 

Earnings recovery delayed: D/G to HOLD 1HFY21 PATMI of HK91.5m (-12.1% YoY) was ahead of our and consensus estimates. This was because the allocation switch-overs to other suppliers were disrupted by Covid-19 and are mostly delayed till 2HFY21. To account for this, we raise FY21E EPS by 24% but cut FY22-23E EPS by 14-20%. This should delay earnings recovery, which we believe is a key re-rating catalyst. As such we D/G to HOLD from BUY. We now value VALUE on 10x blended FY20-21E P/E from ROE-g/COE-g derived 1.2x FY21E P/B.

 

Read More ...


LionelLim8.16Check out our compilation of Target Prices




Share Prices

Counter NameLastChange
AEM Holdings3.510-0.090
Avarga0.250-
Avi-Tech Electronics0.420-0.005
Best World Int.1.360-
CEI0.9700.010
China Sunsine0.510-0.005
CNMC GoldMine0.2800.010
CSE Global0.465-
Food Empire0.590-0.005
Golden Energy0.153-0.002
GSS Energy0.0570.001
ISDN Holdings0.410-0.010
ISOTeam0.1470.002
IX Biopharma0.245-
JB Foods0.5600.005
KSH Holdings0.335-0.005
Medtecs Intl0.955-0.065
Moya Asia0.070-
Nordic Group0.2600.020
Oxley Holdings0.220-0.010
Procurri0.310-
REX International0.145-0.006
Riverstone1.280-0.030
Roxy-Pacific0.355-
SingMedical0.255-
Sri Trang Agro1.140-0.020
Straco Corp.0.585-
Sunningdale Tech1.520-
Sunpower Group0.7300.030
The Trendlines0.090-0.001
UG Healthcare0.655-0.025
Uni-Asia Group0.6350.025
Yangzijiang Shipbldg0.910-0.010

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 1043 guests and one member online

  • josephyeo